| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 50 | 2021 | 2286 | 4.000 |
Why?
|
| Inflammatory Bowel Diseases | 34 | 2021 | 2429 | 2.720 |
Why?
|
| Gastrointestinal Agents | 8 | 2019 | 511 | 1.540 |
Why?
|
| Receptors, Chemokine | 9 | 2015 | 652 | 1.490 |
Why?
|
| Capsule Endoscopy | 6 | 2018 | 107 | 1.360 |
Why?
|
| Colitis, Ulcerative | 20 | 2020 | 1920 | 1.300 |
Why?
|
| Colitis | 10 | 2017 | 1238 | 1.120 |
Why?
|
| Intestinal Mucosa | 18 | 2022 | 3041 | 1.060 |
Why?
|
| Pouchitis | 6 | 2013 | 64 | 1.010 |
Why?
|
| Early Growth Response Transcription Factors | 2 | 2015 | 32 | 0.980 |
Why?
|
| Colonic Pouches | 7 | 2013 | 122 | 0.970 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2015 | 4349 | 0.920 |
Why?
|
| Antibodies, Monoclonal | 15 | 2015 | 9244 | 0.860 |
Why?
|
| Intestine, Small | 10 | 2019 | 1217 | 0.820 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2015 | 505 | 0.790 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2018 | 1805 | 0.700 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2011 | 889 | 0.700 |
Why?
|
| Peritoneal Diseases | 1 | 2020 | 76 | 0.690 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2021 | 179 | 0.690 |
Why?
|
| Omentum | 1 | 2020 | 168 | 0.670 |
Why?
|
| Perineum | 1 | 2020 | 212 | 0.630 |
Why?
|
| Antibodies, Fungal | 3 | 2012 | 33 | 0.630 |
Why?
|
| Methyltransferases | 2 | 2014 | 373 | 0.630 |
Why?
|
| Azathioprine | 4 | 2014 | 354 | 0.630 |
Why?
|
| Biological Products | 3 | 2017 | 948 | 0.580 |
Why?
|
| Sweet Syndrome | 1 | 2018 | 56 | 0.580 |
Why?
|
| Mesalamine | 1 | 2018 | 133 | 0.570 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 551 | 0.560 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2015 | 304 | 0.540 |
Why?
|
| Celiac Disease | 4 | 2022 | 821 | 0.540 |
Why?
|
| Pericarditis | 1 | 2018 | 136 | 0.530 |
Why?
|
| Parturition | 1 | 2020 | 453 | 0.520 |
Why?
|
| Interleukin-12 | 3 | 2017 | 581 | 0.510 |
Why?
|
| Colon | 6 | 2015 | 1797 | 0.500 |
Why?
|
| Immunity, Mucosal | 6 | 2014 | 498 | 0.500 |
Why?
|
| Hysterectomy | 1 | 2020 | 863 | 0.490 |
Why?
|
| Flagellin | 5 | 2008 | 124 | 0.480 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2015 | 65 | 0.470 |
Why?
|
| Meningoencephalitis | 1 | 2015 | 82 | 0.460 |
Why?
|
| Cryptococcus neoformans | 1 | 2015 | 110 | 0.460 |
Why?
|
| Nod2 Signaling Adaptor Protein | 5 | 2010 | 86 | 0.460 |
Why?
|
| Paresthesia | 1 | 2015 | 159 | 0.450 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2017 | 1814 | 0.450 |
Why?
|
| Integrins | 2 | 2017 | 839 | 0.440 |
Why?
|
| Interleukin-18 | 2 | 2005 | 251 | 0.420 |
Why?
|
| Endometriosis | 1 | 2020 | 868 | 0.400 |
Why?
|
| Receptors, CCR | 6 | 2014 | 37 | 0.400 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 376 | 0.390 |
Why?
|
| Cytomegalovirus Infections | 2 | 2013 | 838 | 0.390 |
Why?
|
| Chemokines, CC | 3 | 2003 | 285 | 0.390 |
Why?
|
| Immunosuppressive Agents | 6 | 2015 | 4215 | 0.380 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2013 | 125 | 0.380 |
Why?
|
| Colonic Diseases | 1 | 2013 | 204 | 0.380 |
Why?
|
| Cytokines | 9 | 2017 | 7438 | 0.380 |
Why?
|
| Gram-Negative Bacterial Infections | 4 | 1997 | 239 | 0.370 |
Why?
|
| Forkhead Transcription Factors | 3 | 2016 | 1627 | 0.360 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 518 | 0.350 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 682 | 0.350 |
Why?
|
| Myocarditis | 1 | 2018 | 802 | 0.350 |
Why?
|
| Xanthomonas | 4 | 1997 | 17 | 0.340 |
Why?
|
| Antigens, Bacterial | 5 | 2007 | 1148 | 0.330 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2013 | 527 | 0.330 |
Why?
|
| Sarcoidosis | 1 | 2015 | 535 | 0.330 |
Why?
|
| Spinal Cord | 2 | 2015 | 1811 | 0.310 |
Why?
|
| Abdominal Pain | 1 | 2015 | 1069 | 0.310 |
Why?
|
| Guanine Nucleotides | 1 | 2008 | 55 | 0.300 |
Why?
|
| Thionucleotides | 1 | 2008 | 107 | 0.300 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1594 | 0.300 |
Why?
|
| T-Lymphocytes | 8 | 2024 | 10263 | 0.300 |
Why?
|
| Diarrhea | 3 | 2015 | 1317 | 0.290 |
Why?
|
| Chemokines | 2 | 2004 | 963 | 0.290 |
Why?
|
| Caspase 8 | 1 | 2008 | 198 | 0.290 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 5 | 2008 | 297 | 0.290 |
Why?
|
| Fever | 1 | 2015 | 1607 | 0.280 |
Why?
|
| Th1 Cells | 3 | 2017 | 1040 | 0.280 |
Why?
|
| Humans | 112 | 2024 | 766812 | 0.280 |
Why?
|
| Interferon-gamma | 3 | 2009 | 3157 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1996 | 0.270 |
Why?
|
| Hernia, Umbilical | 1 | 2008 | 102 | 0.270 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 3114 | 0.270 |
Why?
|
| Antibodies, Bacterial | 2 | 2012 | 1477 | 0.260 |
Why?
|
| Esophageal Diseases | 1 | 2007 | 167 | 0.260 |
Why?
|
| Caspase 3 | 1 | 2008 | 730 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2823 | 0.250 |
Why?
|
| Ileitis | 1 | 2005 | 40 | 0.250 |
Why?
|
| Dextrans | 1 | 2008 | 574 | 0.250 |
Why?
|
| Porins | 6 | 2010 | 78 | 0.250 |
Why?
|
| Miniaturization | 1 | 2005 | 151 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2005 | 588 | 0.240 |
Why?
|
| Mucous Membrane | 3 | 2019 | 659 | 0.240 |
Why?
|
| Telemetry | 1 | 2005 | 201 | 0.230 |
Why?
|
| Hyaluronic Acid | 1 | 2008 | 484 | 0.230 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 646 | 0.230 |
Why?
|
| Female | 69 | 2021 | 396532 | 0.220 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 6965 | 0.220 |
Why?
|
| Antibody Formation | 2 | 2007 | 1392 | 0.210 |
Why?
|
| Adult | 54 | 2021 | 223305 | 0.210 |
Why?
|
| Trachea | 3 | 1998 | 1094 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 4652 | 0.210 |
Why?
|
| Superantigens | 4 | 2007 | 124 | 0.210 |
Why?
|
| Musculoskeletal Diseases | 1 | 2009 | 598 | 0.210 |
Why?
|
| Anemia | 1 | 2012 | 1514 | 0.210 |
Why?
|
| Fetal Distress | 2 | 2019 | 39 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.200 |
Why?
|
| Immunocompromised Host | 3 | 2015 | 865 | 0.200 |
Why?
|
| Antigens, CD20 | 1 | 2003 | 199 | 0.200 |
Why?
|
| Macrophages | 3 | 2015 | 5784 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 18076 | 0.190 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 12808 | 0.190 |
Why?
|
| Vulvar Diseases | 1 | 2021 | 64 | 0.190 |
Why?
|
| Proctocolectomy, Restorative | 4 | 2013 | 191 | 0.180 |
Why?
|
| Biological Therapy | 2 | 2020 | 140 | 0.180 |
Why?
|
| Ileum | 3 | 2007 | 558 | 0.180 |
Why?
|
| Th17 Cells | 2 | 2017 | 790 | 0.180 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 384 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2010 | 1940 | 0.170 |
Why?
|
| Gastric Antral Vascular Ectasia | 1 | 2019 | 6 | 0.170 |
Why?
|
| Male | 54 | 2019 | 364154 | 0.170 |
Why?
|
| Glutens | 1 | 2022 | 240 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2009 | 4410 | 0.170 |
Why?
|
| Phenotype | 5 | 2018 | 16722 | 0.170 |
Why?
|
| Angiodysplasia | 1 | 2019 | 22 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 2 | 2017 | 1612 | 0.160 |
Why?
|
| Lymphocyte Subsets | 1 | 2000 | 313 | 0.160 |
Why?
|
| Pyloric Stenosis | 1 | 1999 | 28 | 0.160 |
Why?
|
| Antibodies | 5 | 2010 | 2421 | 0.160 |
Why?
|
| Fetus | 4 | 1999 | 1878 | 0.160 |
Why?
|
| Treatment Outcome | 19 | 2019 | 65286 | 0.160 |
Why?
|
| Middle Aged | 40 | 2021 | 223267 | 0.160 |
Why?
|
| Interleukin-10 | 3 | 2015 | 1182 | 0.150 |
Why?
|
| Coculture Techniques | 3 | 2007 | 1337 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2007 | 2678 | 0.150 |
Why?
|
| Interleukin-23 | 2 | 2017 | 202 | 0.150 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 256 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2018 | 1884 | 0.140 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2017 | 59 | 0.140 |
Why?
|
| Immune System | 1 | 2003 | 800 | 0.140 |
Why?
|
| Antigens, Fungal | 3 | 2007 | 69 | 0.140 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1998 | 244 | 0.140 |
Why?
|
| Acidosis | 1 | 2019 | 271 | 0.140 |
Why?
|
| Fetoscopy | 1 | 1998 | 140 | 0.140 |
Why?
|
| Adolescent | 23 | 2021 | 88902 | 0.140 |
Why?
|
| Immunoglobulins | 2 | 2014 | 853 | 0.130 |
Why?
|
| Colonoscopy | 3 | 2021 | 1409 | 0.130 |
Why?
|
| Janus Kinases | 1 | 2017 | 253 | 0.130 |
Why?
|
| Recurrence | 5 | 2024 | 8507 | 0.130 |
Why?
|
| Proctocolitis | 1 | 2016 | 31 | 0.130 |
Why?
|
| Intestines | 3 | 2014 | 1904 | 0.130 |
Why?
|
| Young Adult | 11 | 2021 | 59939 | 0.130 |
Why?
|
| Latent Tuberculosis | 1 | 2018 | 223 | 0.130 |
Why?
|
| Anastomosis, Surgical | 4 | 2013 | 992 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2000 | 1266 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2019 | 1126 | 0.120 |
Why?
|
| Smad2 Protein | 1 | 2015 | 144 | 0.120 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 2 | 2005 | 12 | 0.120 |
Why?
|
| Body Fluids | 1 | 1997 | 321 | 0.120 |
Why?
|
| Meningitis, Bacterial | 1 | 1997 | 222 | 0.120 |
Why?
|
| Bursitis | 1 | 1996 | 85 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 506 | 0.120 |
Why?
|
| Emergency Treatment | 1 | 1999 | 495 | 0.120 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 2209 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 1172 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1561 | 0.120 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2014 | 9 | 0.120 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 39312 | 0.120 |
Why?
|
| Cholangitis | 1 | 1995 | 110 | 0.120 |
Why?
|
| Ulcer | 1 | 2016 | 203 | 0.120 |
Why?
|
| Mucoproteins | 1 | 2014 | 49 | 0.120 |
Why?
|
| Immunity, Innate | 3 | 2014 | 3079 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 384 | 0.110 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15912 | 0.110 |
Why?
|
| Lung | 4 | 2010 | 10068 | 0.110 |
Why?
|
| Biopsy | 3 | 2015 | 6779 | 0.110 |
Why?
|
| Apolipoprotein A-I | 1 | 2015 | 305 | 0.110 |
Why?
|
| Apoptosis | 2 | 2008 | 9514 | 0.110 |
Why?
|
| Retrospective Studies | 18 | 2021 | 81657 | 0.110 |
Why?
|
| Antifungal Agents | 2 | 2015 | 769 | 0.110 |
Why?
|
| Wound Healing | 2 | 2019 | 2800 | 0.110 |
Why?
|
| Jurkat Cells | 1 | 2014 | 740 | 0.110 |
Why?
|
| Ganciclovir | 1 | 2013 | 256 | 0.100 |
Why?
|
| Cell Movement | 3 | 2017 | 5204 | 0.100 |
Why?
|
| Fetal Diseases | 1 | 1998 | 915 | 0.100 |
Why?
|
| Acetylation | 1 | 2015 | 1055 | 0.100 |
Why?
|
| Aged | 33 | 2019 | 171344 | 0.100 |
Why?
|
| Phenylalanine | 1 | 2014 | 367 | 0.100 |
Why?
|
| Quinazolinones | 1 | 2014 | 219 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2008 | 4747 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2416 | 0.100 |
Why?
|
| Quality of Life | 3 | 2015 | 13476 | 0.100 |
Why?
|
| Sheep | 4 | 1998 | 1448 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1889 | 0.100 |
Why?
|
| Blood Sedimentation | 1 | 2012 | 234 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2013 | 266 | 0.100 |
Why?
|
| Immunophenotyping | 3 | 2017 | 1867 | 0.090 |
Why?
|
| Animals | 20 | 2017 | 168939 | 0.090 |
Why?
|
| Sensitivity and Specificity | 7 | 2009 | 14653 | 0.090 |
Why?
|
| Hematocrit | 1 | 2012 | 622 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2015 | 1442 | 0.090 |
Why?
|
| Pyrroles | 1 | 2017 | 1121 | 0.090 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2010 | 28 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15425 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 1131 | 0.090 |
Why?
|
| Orbital Myositis | 1 | 2010 | 25 | 0.090 |
Why?
|
| Diagnosis, Differential | 5 | 2010 | 12985 | 0.090 |
Why?
|
| Eimeria | 1 | 2009 | 2 | 0.090 |
Why?
|
| Remission Induction | 2 | 2015 | 2413 | 0.090 |
Why?
|
| Pseudomonas fluorescens | 2 | 2006 | 22 | 0.090 |
Why?
|
| Coccidiosis | 1 | 2009 | 10 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2014 | 16044 | 0.080 |
Why?
|
| Antitubercular Agents | 1 | 2018 | 1380 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2012 | 462 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 3229 | 0.080 |
Why?
|
| Ferritins | 1 | 2012 | 601 | 0.080 |
Why?
|
| Child | 15 | 2024 | 80670 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14473 | 0.080 |
Why?
|
| Disease Models, Animal | 7 | 2017 | 18329 | 0.080 |
Why?
|
| Lymph Nodes | 3 | 2007 | 3468 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 2057 | 0.080 |
Why?
|
| Body Weight | 3 | 2009 | 4626 | 0.080 |
Why?
|
| Gastric Balloon | 1 | 2009 | 36 | 0.080 |
Why?
|
| Leukocytes | 1 | 2017 | 2034 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10745 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2971 | 0.080 |
Why?
|
| Endoscopy | 2 | 1998 | 1854 | 0.080 |
Why?
|
| Gliadin | 1 | 2009 | 80 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 2013 | 754 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2020 | 2038 | 0.080 |
Why?
|
| Capsule Endoscopes | 1 | 2008 | 13 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
| Risk Factors | 9 | 2015 | 74889 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 420 | 0.080 |
Why?
|
| Piperidines | 1 | 2017 | 1663 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 6225 | 0.080 |
Why?
|
| Case-Control Studies | 8 | 2018 | 22248 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 2 | 2009 | 414 | 0.080 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 2127 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2017 | 5502 | 0.070 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2010 | 174 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1752 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2017 | 23618 | 0.070 |
Why?
|
| Anus Neoplasms | 1 | 2012 | 336 | 0.070 |
Why?
|
| Methotrexate | 1 | 2014 | 1719 | 0.070 |
Why?
|
| Anal Canal | 2 | 2007 | 375 | 0.070 |
Why?
|
| Rectum | 2 | 2016 | 897 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2007 | 11062 | 0.070 |
Why?
|
| Transglutaminases | 1 | 2009 | 200 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 238 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2008 | 131 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 1911 | 0.070 |
Why?
|
| Immunologic Memory | 2 | 2005 | 1377 | 0.070 |
Why?
|
| Antimetabolites | 1 | 2007 | 128 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 280 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2008 | 332 | 0.070 |
Why?
|
| Binding Sites | 1 | 2015 | 6013 | 0.070 |
Why?
|
| Serologic Tests | 1 | 2009 | 382 | 0.070 |
Why?
|
| Ligation | 2 | 1998 | 446 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2012 | 1531 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11924 | 0.070 |
Why?
|
| Prognosis | 6 | 2019 | 29959 | 0.070 |
Why?
|
| Mesentery | 1 | 2007 | 201 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2014 | 18986 | 0.060 |
Why?
|
| Radiography | 3 | 2009 | 6968 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2012 | 3226 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2009 | 768 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9546 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2005 | 9 | 0.060 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 306 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2007 | 5890 | 0.060 |
Why?
|
| Colectomy | 2 | 2007 | 696 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2887 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 1622 | 0.060 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 734 | 0.060 |
Why?
|
| Granuloma | 1 | 2007 | 329 | 0.060 |
Why?
|
| Forecasting | 2 | 2008 | 2936 | 0.060 |
Why?
|
| Thrombocytosis | 1 | 2005 | 88 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2846 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4424 | 0.060 |
Why?
|
| Esophagoscopy | 1 | 2007 | 398 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2595 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2017 | 3043 | 0.060 |
Why?
|
| HLA-DR3 Antigen | 1 | 2004 | 24 | 0.060 |
Why?
|
| Age of Onset | 1 | 2012 | 3343 | 0.060 |
Why?
|
| Pregnancy | 5 | 2020 | 30236 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2018 | 6408 | 0.060 |
Why?
|
| Base Sequence | 1 | 2015 | 12415 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2015 | 8310 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2014 | 1982 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2015 | 2694 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5795 | 0.060 |
Why?
|
| Digestive System | 2 | 2002 | 244 | 0.060 |
Why?
|
| Bronchiolitis | 1 | 2010 | 492 | 0.060 |
Why?
|
| Inflammation | 2 | 2000 | 10863 | 0.060 |
Why?
|
| Lymphocyte Cooperation | 1 | 2003 | 112 | 0.050 |
Why?
|
| Receptors, CXCR3 | 1 | 2004 | 240 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 36570 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2008 | 2133 | 0.050 |
Why?
|
| Capsules | 1 | 2004 | 192 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2505 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 684 | 0.050 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2004 | 491 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 812 | 0.050 |
Why?
|
| Drug Tolerance | 1 | 2005 | 365 | 0.050 |
Why?
|
| Cohort Studies | 10 | 2021 | 41706 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 1550 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1183 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17609 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1150 | 0.050 |
Why?
|
| Tuberculin Test | 2 | 2018 | 205 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2476 | 0.050 |
Why?
|
| Immunization | 1 | 2006 | 1218 | 0.050 |
Why?
|
| Thorax | 1 | 2005 | 555 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 40149 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 940 | 0.050 |
Why?
|
| Catheterization | 2 | 1998 | 1429 | 0.050 |
Why?
|
| Sepsis | 1 | 1995 | 2604 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2007 | 10451 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 22351 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1345 | 0.050 |
Why?
|
| Prevalence | 1 | 2018 | 15835 | 0.050 |
Why?
|
| Mice | 8 | 2017 | 81898 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2013 | 3070 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3853 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 3803 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2004 | 1757 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6214 | 0.040 |
Why?
|
| Feces | 1 | 2006 | 1505 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 696 | 0.040 |
Why?
|
| Living Donors | 1 | 2004 | 647 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 1055 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4853 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4570 | 0.040 |
Why?
|
| Transfection | 1 | 2007 | 5755 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 610 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2021 | 42577 | 0.040 |
Why?
|
| Health Surveys | 1 | 2009 | 4055 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12064 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2009 | 6613 | 0.040 |
Why?
|
| Arthritis | 1 | 2004 | 684 | 0.040 |
Why?
|
| Duodenal Neoplasms | 1 | 1999 | 114 | 0.040 |
Why?
|
| Fetal Hypoxia | 1 | 1998 | 30 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2228 | 0.040 |
Why?
|
| Fetal Organ Maturity | 1 | 1998 | 83 | 0.040 |
Why?
|
| Plasmacytoma | 1 | 1999 | 171 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6548 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10816 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2392 | 0.040 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 59548 | 0.040 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 1104 | 0.040 |
Why?
|
| Adiposity | 1 | 2008 | 1892 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2019 | 382 | 0.040 |
Why?
|
| Fistula | 1 | 1999 | 213 | 0.040 |
Why?
|
| Prospective Studies | 10 | 2018 | 54872 | 0.040 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1999 | 110 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 1150 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 661 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2008 | 24299 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2007 | 2328 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 1791 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3723 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 1998 | 169 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2003 | 1592 | 0.040 |
Why?
|
| Uterine Neoplasms | 2 | 1996 | 1424 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 3235 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4559 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 6306 | 0.040 |
Why?
|
| Linear Models | 3 | 2015 | 5873 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2017 | 102 | 0.030 |
Why?
|
| Melanoma | 1 | 2015 | 5702 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20710 | 0.030 |
Why?
|
| Scalp | 1 | 2019 | 390 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8540 | 0.030 |
Why?
|
| Fungemia | 1 | 1996 | 57 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2019 | 313 | 0.030 |
Why?
|
| Amphotericin B | 1 | 1996 | 140 | 0.030 |
Why?
|
| Fluconazole | 1 | 1996 | 154 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2024 | 2925 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5860 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4787 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2016 | 124 | 0.030 |
Why?
|
| Bacteriuria | 1 | 1996 | 102 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6507 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 26309 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2000 | 1077 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2013 | 15831 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 18397 | 0.030 |
Why?
|
| Family | 1 | 2006 | 3209 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2551 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2002 | 1276 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 2478 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 1997 | 540 | 0.030 |
Why?
|
| Thalidomide | 1 | 1999 | 886 | 0.030 |
Why?
|
| Budesonide | 1 | 2015 | 162 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 1997 | 1001 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5749 | 0.030 |
Why?
|
| Acute Disease | 2 | 2008 | 7240 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2008 | 13050 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 1995 | 276 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 1852 | 0.030 |
Why?
|
| Candidiasis | 1 | 1996 | 372 | 0.030 |
Why?
|
| Pressure | 1 | 1997 | 1172 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 2 | 2008 | 1365 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2009 | 8533 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 65 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2008 | 1996 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 548 | 0.030 |
Why?
|
| Age Distribution | 1 | 1999 | 2869 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1308 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2004 | 4926 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2010 | 2659 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 804 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2019 | 1367 | 0.020 |
Why?
|
| Incidence | 4 | 2008 | 21527 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1998 | 947 | 0.020 |
Why?
|
| Infant | 2 | 2008 | 36459 | 0.020 |
Why?
|
| Organ Size | 1 | 1997 | 2262 | 0.020 |
Why?
|
| Europe | 2 | 2009 | 3430 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 311 | 0.020 |
Why?
|
| Registries | 1 | 2007 | 8352 | 0.020 |
Why?
|
| Alleles | 3 | 2008 | 6896 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20146 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4914 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2004 | 2011 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1995 | 1838 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3942 | 0.020 |
Why?
|
| Prednisone | 1 | 2015 | 1566 | 0.020 |
Why?
|
| Mannans | 1 | 2010 | 58 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2009 | 29 | 0.020 |
Why?
|
| Chronic Disease | 4 | 2008 | 9358 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2010 | 94 | 0.020 |
Why?
|
| Cholangiocarcinoma | 1 | 1995 | 562 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2270 | 0.020 |
Why?
|
| Phospholipase C delta | 1 | 2009 | 7 | 0.020 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 1403 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 100 | 0.020 |
Why?
|
| Pain | 1 | 2004 | 5098 | 0.020 |
Why?
|
| Obesity | 2 | 2008 | 13090 | 0.020 |
Why?
|
| Bacteremia | 1 | 1996 | 987 | 0.020 |
Why?
|
| Liposomes | 1 | 2012 | 787 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26387 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7585 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1997 | 1255 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1997 | 1547 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 276 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
| Knee Joint | 1 | 1996 | 1682 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 828 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
| Cross Infection | 1 | 1996 | 1427 | 0.020 |
Why?
|
| Diastole | 1 | 2009 | 784 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2008 | 404 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2016 | 1790 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12795 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2017 | 4033 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15652 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2010 | 910 | 0.020 |
Why?
|
| Ileostomy | 1 | 2006 | 122 | 0.020 |
Why?
|
| Fibrosis | 2 | 2004 | 2078 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2007 | 527 | 0.020 |
Why?
|
| Carcinoma | 1 | 1997 | 2325 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2006 | 141 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2009 | 818 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2008 | 540 | 0.020 |
Why?
|
| Chickenpox | 1 | 2006 | 95 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 640 | 0.020 |
Why?
|
| Mutation | 3 | 2010 | 30214 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1999 | 5990 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 992 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2007 | 778 | 0.010 |
Why?
|
| Length of Stay | 1 | 1999 | 6491 | 0.010 |
Why?
|
| Genome, Human | 2 | 2008 | 4443 | 0.010 |
Why?
|
| Tuberculin | 1 | 2004 | 63 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2008 | 1211 | 0.010 |
Why?
|
| Interleukin-17 | 1 | 2010 | 923 | 0.010 |
Why?
|
| Anthropometry | 1 | 2008 | 1336 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 915 | 0.010 |
Why?
|
| Proteins | 2 | 2009 | 6002 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.010 |
Why?
|
| Los Angeles | 1 | 2004 | 244 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2747 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2006 | 582 | 0.010 |
Why?
|
| Platelet Count | 1 | 2005 | 784 | 0.010 |
Why?
|
| California | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 14073 | 0.010 |
Why?
|
| India | 1 | 2009 | 2335 | 0.010 |
Why?
|
| Morbidity | 1 | 2007 | 1754 | 0.010 |
Why?
|
| Intestinal Perforation | 1 | 2004 | 254 | 0.010 |
Why?
|
| Siblings | 1 | 2006 | 828 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 1996 | 13489 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 2006 | 529 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3621 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 4618 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10619 | 0.010 |
Why?
|
| Genotype | 2 | 2006 | 13036 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 4056 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8623 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4526 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2008 | 2253 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 238 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 1999 | 122 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2004 | 8728 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2902 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 1998 | 77 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 27158 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1999 | 610 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2004 | 1129 | 0.010 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 1996 | 66 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 2712 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 2004 | 903 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3624 | 0.010 |
Why?
|
| Oximetry | 1 | 1998 | 461 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2006 | 1543 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 13276 | 0.010 |
Why?
|
| Electromyography | 1 | 1999 | 1398 | 0.010 |
Why?
|
| Arteries | 1 | 1999 | 1123 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 3833 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 12536 | 0.010 |
Why?
|
| Disease Management | 1 | 2004 | 2533 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 4752 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13644 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1874 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 9613 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10384 | 0.010 |
Why?
|
| Medical Records | 1 | 1996 | 1408 | 0.010 |
Why?
|
| Causality | 1 | 1996 | 1252 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 1996 | 804 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1996 | 1972 | 0.010 |
Why?
|
| Mass Screening | 1 | 2004 | 5454 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1995 | 21162 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8928 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1996 | 1381 | 0.000 |
Why?
|
| United States | 1 | 2015 | 72945 | 0.000 |
Why?
|
| Sarcoma | 1 | 1996 | 1802 | 0.000 |
Why?
|
| Survival Rate | 1 | 1996 | 12826 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 6359 | 0.000 |
Why?
|
| Neoplasms | 1 | 1996 | 22350 | 0.000 |
Why?
|